Method of prophlactically treating infection using a recombinant fibrinogen binding protein clumping factor A (ClfA) or fragment thereof

Assignee

• Glaxosmithkline Biologicals Sa
• Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin

Inventors

• Timothy Paul Foster (6 patents)
• Judy Higgins (3 patents)
• Elisabet Josefsson (7 patents)
• Joan Geoghegan (3 patents)
• Guy Dequesne (2 patents)
• Andrej Tarkowski (6 patents)

View full patent text on Google Patents →